Vibration Technology Makes It Possible to Obtain Standardized Biological Preparations: Vibrational Iterations Based on Cultured Cells

Cell-based therapy is a promising direction for the treatment of various diseases. However, it is associated with several problems, primarily related to reproducibility and standardization. In this context, the development of new methods for the production of cell-based preparations is of particular relevance. Recently, a novel technology named ‘crossing’ has been developed. It comprises the multi-stage vibrational processing of two closely spaced test tubes containing the initial substance and a neutral carrier (water or lactose). As a result, the neutral carrier acquires some properties of the initial substance, and artificial products, vibrational iterations, are obtained. Some vibrational iterations are also capable of exerting a modifying effect on the initial substance (or its target in the body), changing its physico-chemical/biological properties. Earlier, we demonstrated the possibility of obtaining vibrational iterations from biological molecules (antibodies). In this study, we evaluated the biological effects of vibrational iterations obtained by the crossing technology using cells grown in culture. This work shows that vibrational iterations obtained from CHO-S cell culture affect the ability of CHO-S cells to utilize glucose in the presence of insulin. The data demonstrate the prospect of developing fundamentally new biological drugs based on vibrational iterations, including for the treatment of diabetes mellitus.